Nabolic Strong
High concentration injectable anabolic for equines
NABOLIC STRONG is an injectable anabolic based on stanozolol, especially designed for top competition equines. Its high concentration (50 mg per ml) gives it a high anabolic power and makes it possible to extend the time interval between applications. Stanozolol, the active ingredient of Nabolic Strong, is characterized by a very high anabolic capacity and the lowest androgenic capacity among all the steroid anabolics, a feature that positions it among the best anabolics for equines.
NABOLIC STRONG is indicated for the recovery of organisms weakened by advanced age, diseases and their convalescence, traumatic injuries or excessive work. It is useful in cases of fractures, orthopedic conditions, muscular dystrophies and general bone deficiencies. It is also indicated as an appetite stimulant and to increase strength and vitality.
Equines: 1 ml per 100 kg of body weight (50 mg of stanozolol per 100 kg) at weekly intervals, or 2 ml per 100 kg of body weight (100 mg of stanozolol per 100 kg) every 15 days.
The treatment may be continued for 4 weeks or according to the Veterinarian’s criterion. In clinical treatments, many animals do not require more than one or two doses to obtain the expected therapeutic results.
NABOLIC STRONG must be applied exclusively by deep intramuscular route, performing the aspiration test to be sure of avoiding the intravenous route.
SHAKE before use to homogenize the content. To take the best advantage of the product, it is recommended the concomitant use with Aminoacids Vit to favour protein synthesis.
Ampoule bottle x 30 ml.
When applied and dosed as indicated, the product has no side effects or incompatibilities: at the recommended doses, no undesirable side effects were observed.
In cases of overdose and prolonged treatments, signs of virilization and cholestatic hepatotoxicity may appear, clinically manifested by anorexia, skin disorders, constipation, halitosis, flatulence, tympanism, etc., and biochemically characterized by an increase in alkaline phosphatase, bilirubin, total cholesterol and GGT. Sodium and water retention with edema production, as well as diffuse alopecia localized on the rib cage, are also possible. These processes are reversible once the drug is discontinued.
Do not administer to pregnant mares, to stallions during the breeding season, or to horses intended for human consumption. Do not administer in case of malignant tumors of any etiology. Do not administer together with adrenocorticotrophic hormones and corticoids. Do not overdose.
Do not administer to growing animals, as it may stop growth by accelerating epiphyseal closure; this contraindication does not apply to horses over 24 months of age.
Animals with renal and/or cardiac deficiencies should be monitored by the Veterinary Doctor during treatment, as anabolic therapy may be accompanied by sodium and water retention.
Sales under prescription only.
Ampoule bottle x 30 ml.
Micronized stanozolol …………………………………. 5 g
Formulation agents q.s. …………………………….. 100 ml
THE PRODUCT MUST BE APPLIED BY A VETERINARY DOCTOR
